Airline Access to Emergency Epinephrine Act of 2015

This bill directs the Federal Aviation Administration (FAA) to clarify, and to require air carriers (including foreign carriers) to clarify, that 1:1,000 epinephrine ampules included in emergency medical kits carried on aircraft are to be used for the treatment of anaphylaxis.

The FAA shall require an air carrier to:

• carry on each aircraft at least two packs of epinephrine auto-injectors for use as the initial treatment for anaphylaxis,
• replace them upon expiration or use, and
• train air crewmembers on how to recognize the symptoms of an acute allergic reaction and administer auto-injectable epinephrine.

The Government Accountability Office shall report to Congress on air carrier policies relating to passengers with food allergies.